Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
mepolizumab interleukin-5 biotech Successful target TTD , drugbank , DGIDB Pulmonary Eosinophilia[MeSHID:D011657]
Maintenance[MeSHID:D008283]
Eosinophilia[MeSHID:D004802]
Neoplasm Metastasis[MeSHID:D009362]
Systemic Vasculitis[MeSHID:D056647]
Hypereosinophilic syndrome[MeSHID:D017681]
eosinophil[MeSHID:D004804]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Asthma[MeSHID:D001249]		 45.47 approved,investigational antagonist,inhibitor
mepolizumab interleukin-5 biotech Successful target TTD , drugbank , DGIDB Pulmonary Eosinophilia[MeSHID:D011657]
Maintenance[MeSHID:D008283]
Eosinophilia[MeSHID:D004802]
Neoplasm Metastasis[MeSHID:D009362]
Systemic Vasculitis[MeSHID:D056647]
Hypereosinophilic syndrome[MeSHID:D017681]
eosinophil[MeSHID:D004804]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Asthma[MeSHID:D001249]		 45.47 approved,investigational antagonist
click here to return to the previous page